These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 7925616)

  • 1. Rat liver and kidney contain high densities of sigma 1 and sigma 2 receptors: characterization by ligand binding and photoaffinity labeling.
    Hellewell SB; Bruce A; Feinstein G; Orringer J; Williams W; Bowen WD
    Eur J Pharmacol; 1994 Jun; 268(1):9-18. PubMed ID: 7925616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A sigma-like binding site in rat pheochromocytoma (PC12) cells: decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain.
    Hellewell SB; Bowen WD
    Brain Res; 1990 Sep; 527(2):244-53. PubMed ID: 2174717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines.
    Vilner BJ; John CS; Bowen WD
    Cancer Res; 1995 Jan; 55(2):408-13. PubMed ID: 7812973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,3-Di(2-[5-3H]tolyl)guanidine labels more than one site in rat forebrain.
    Codd EE; Shank RP
    Eur J Pharmacol; 1992 Jul; 217(2-3):149-52. PubMed ID: 1425936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discrepancies in characterization of sigma sites in the mouse central nervous system.
    Kovács KJ; Larson AA
    Eur J Pharmacol; 1995 Oct; 285(2):127-34. PubMed ID: 8566130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [3H]DTG and [3H](+)-3-PPP label pharmacologically distinct sigma binding sites in guinea pig brain membranes.
    Karbon EW; Naper K; Pontecorvo MJ
    Eur J Pharmacol; 1991 Jan; 193(1):21-7. PubMed ID: 1675607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential solubilization of rat liver sigma 1 and sigma 2 receptors: retention of sigma 2 sites in particulate fractions.
    Torrence-Campbell C; Bowen WD
    Eur J Pharmacol; 1996 May; 304(1-3):201-10. PubMed ID: 8813603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oocytes from Xenopus laevis contain an intrinsic sigma 2-like binding site.
    Patterson TA; Connor M; Appleyard SM; Chavkin C
    Neurosci Lett; 1994 Oct; 180(2):159-62. PubMed ID: 7700571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of sigma ligand-activated receptor subtypes that modulate NMDA-evoked [3H]-noradrenaline release in rat hippocampal slices.
    Monnet FP; de Costa BR; Bowen WD
    Br J Pharmacol; 1996 Sep; 119(1):65-72. PubMed ID: 8872358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (125I)iodoazidococaine, a photoaffinity label for the haloperidol-sensitive sigma receptor.
    Kahoun JR; Ruoho AE
    Proc Natl Acad Sci U S A; 1992 Feb; 89(4):1393-7. PubMed ID: 1311097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kappa opioid receptor agonists inhibit sigma-1 (sigma 1) receptor binding in guinea-pig brain, liver and spleen: autoradiographical evidence.
    Brent PJ
    Brain Res; 1996 Jul; 725(2):155-65. PubMed ID: 8836521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and binding characteristics of potential SPECT imaging agents for sigma-1 and sigma-2 binding sites.
    He XS; Bowen WD; Lee KS; Williams W; Weinberger DR; de Costa BR
    J Med Chem; 1993 Mar; 36(5):566-71. PubMed ID: 8496936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ionic zinc may function as an endogenous ligand for the haloperidol-sensitive sigma 2 receptor in rat brain.
    Connor MA; Chavkin C
    Mol Pharmacol; 1992 Sep; 42(3):471-9. PubMed ID: 1406599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of two sigma-like binding sites in the mouse neuroblastoma x rat glioma hybrid cell line NG108-15.
    Georg A; Friedl A
    J Pharmacol Exp Ther; 1991 Nov; 259(2):479-83. PubMed ID: 1658298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding properties of SA4503, a novel and selective sigma 1 receptor agonist.
    Matsuno K; Nakazawa M; Okamoto K; Kawashima Y; Mita S
    Eur J Pharmacol; 1996 Jun; 306(1-3):271-9. PubMed ID: 8813641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple [3H]DTG binding sites in guinea pig cerebellum: evidence for the presence of non-specific binding.
    Basile AS; DeCosta B; Paul IA
    Eur J Pharmacol; 1994 Feb; 252(2):139-46. PubMed ID: 8157054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a (+)-azidophenazocine-sensitive sigma receptor on splenic lymphocytes.
    Garza HH; Mayo S; Bowen WD; DeCosta BR; Carr DJ
    J Immunol; 1993 Nov; 151(9):4672-80. PubMed ID: 7691955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor binding profiles of KB-5492, a novel anti-ulcer agent, at sigma receptors in guinea-pig brain.
    Harada Y; Hara H; Sukamoto T
    Eur J Pharmacol; 1994 May; 256(3):321-8. PubMed ID: 8045277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of specific binding sites for [3H]-1,3-di-o-tolyl-guanidine (DTG) in the rat glioma cell line C6-BU-1.
    Georg A; Friedl A
    Glia; 1992; 6(4):258-63. PubMed ID: 1464457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haloperidol treatment differentially regulates [3H]DTG and [3H](+)-3-PPP labeled sigma binding sites.
    Bailey MA; Karbon EW
    Eur J Pharmacol; 1993 Aug; 240(2-3):243-50. PubMed ID: 7902283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.